Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine therapies for cancer significantly increase the risk of hair loss.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

New alopecia treatments aim for better results and fewer side effects.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Afatinib often causes skin problems that need proactive management.

Social media can help compare the effectiveness and safety of new arthritis medications.

Adding a second method to PROTACs could improve cancer treatment.

AGA might indicate higher risk for severe COVID-19.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

New therapies are being developed that target integrin pathways to treat various diseases.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.